Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Share Price Information for Renalytix Plc (RENX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.50
Bid: 16.00
Ask: 17.00
Change: -1.00 (-5.71%)
Spread: 1.00 (6.25%)
Open: 14.50
High: 16.50
Low: 14.50
Prev. Close: 17.50
RENX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

30 Apr 2024 07:00

RNS Number : 4878M
Renalytix PLC
30 April 2024
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

Renalytix plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

CVI Investments, Inc.

City and country of registered office (if applicable)

Bala Cynwyd, PA, USA

4. Full name of shareholder(s) (if different from 3.) v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

26/04/2024

6. Date on which issuer notified (DD/MM/YYYY):

29/04/2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

5.10%

0%

5.10%

7,866,882

Position of previous notification (if

applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00BYWL4Y04

7,866,882

0.00%

5.10%

0.00%

SUBTOTAL 8. A

7,866,882

5.10%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

CVI Holdings, LLC.

CVI Investments, Inc.

5.10%

0%

5.10%

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

 

Place of completion

401 City Ave Suite 220, Bala Cynwyd, PA 19004

Date of completion

29/04/2024

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFVDSFIAFIS
Date   Source Headline
14th Sep 20217:00 amRNSMount Sinai Initiates Scale-Up of KidneyIntelX
13th Sep 20214:15 pmRNSIssue of shares and TVR
3rd Sep 20217:00 amRNSPresentation at 2021 Wells Fargo Healthcare Conf.
31st Aug 20214:41 pmRNSSecond Price Monitoring Extn
31st Aug 20214:35 pmRNSPrice Monitoring Extension
31st Aug 20219:00 amRNSPrice Monitoring Extension
31st Aug 20217:00 amRNSAppointment of Daniel J. Levangie to Board
26th Aug 20217:00 amRNSPeer reviewed publication
13th Aug 202111:49 amRNSDirector/PDMR Shareholding
6th Aug 20214:42 pmRNSDirector/PDMR Dealing
2nd Aug 202112:00 pmRNSTotal Voting Rights
30th Jul 20214:25 pmRNSDirector/PDMR Dealing
28th Jul 20217:00 amRNSAppointment of Ann Berman to Board of Directors
23rd Jul 202111:30 amRNSDirector/PDMR Shareholding
22nd Jul 20217:00 amRNSVP of Global Quality and Regulatory Appointment
19th Jul 20213:02 pmRNSExercise of Options and TVR
7th Jul 20217:00 amRNSExercise of options, PDMR transaction and TVR
1st Jul 20213:51 pmRNSDirectorate Change
1st Jul 20217:00 amRNSTotal Voting Rights
28th Jun 202111:50 amRNSDirector/PDMR Shareholding
28th Jun 20217:00 amRNSNew data for KidneyIntelX
25th Jun 20215:25 pmRNSDirector/PDMR Dealing
25th Jun 202112:52 pmRNSExercise of options
24th Jun 20212:00 pmRNSChange of name
22nd Jun 20211:25 pmRNSDirector/PDMR Shareholding - Replacement
22nd Jun 202110:57 amRNSDirector/PDMR Shareholding
15th Jun 20217:00 amRNSFinancial Results for Third Quarter of FY 2021
10th Jun 20217:00 amRNSNotice of Results & Change of Auditor
7th Jun 20217:00 amRNSKey new hires to drive commercialization strategy
3rd Jun 20217:00 amRNSUtility Study
25th May 20217:00 amRNSDirector/PDMR Shareholding
21st May 20217:02 amRNSDirector/PDMR Dealing
19th May 20218:00 amRNSPartnership
22nd Apr 20212:06 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:00 pmRNSPrice Monitoring Extension
22nd Apr 202111:05 amRNSSecond Price Monitoring Extn
22nd Apr 202111:00 amRNSPrice Monitoring Extension
22nd Apr 20217:00 amRNS10-year US Government contract award
20th Apr 20217:00 amRNSPositive clinical outcome data for KidneyIntelX
19th Apr 20217:00 amRNSDirector/PDMR Shareholding
14th Apr 20217:00 amRNSExclusive option agreement
8th Apr 20217:00 amRNSClinical Utility Study
6th Apr 20217:00 amRNSClinical findings published in Diabetologia
15th Mar 20217:00 amRNSUpdate on Finalization of MCIT Rule
4th Mar 20216:00 pmRNSIssue of shares, PDMR Dealing and TVR
2nd Mar 20217:02 amRNSFinancial Results for Second Quarter of FY 2021
2nd Mar 20217:00 amRNSHalf-year Report
24th Feb 20217:00 amRNSUniversity of Utah Kidney Health Partnership
23rd Feb 20217:00 amRNSNotice of Results
4th Feb 20217:00 amRNSASN & Renalytix to Co-Host Capital Markets Day

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.